Leprosy - Symptoms & Treatment
Leprosy is caused by bacteria or germs called Mycobacterium leprae. It is an infection that affects the skin and the nerves of the hands and feet and can also cause problems in the eyes and nose and medical name for leprosy is Hansen's disease. The germs probably enter the body through the nose and possibly through broken skin. The germs get in the air through nasal discharge of untreated lepromatous patients. Tuberculoid leprosy symptoms are a few well-defined skin lesions that are numb. Lepromatous leprosy symptoms are a chronically stuffy nose and many skin lesions and nodules on both sides of the body. There are three types of the disease. The generalised form - the lepromatous form - attacks peripheral nerves, the skin, the hands and feet, the mucous membranes (such as the lining of the nose), and the eyes.
Tuberculoid leprosy symptoms are a few well-defined skin lesions that are numb. The third type is known as borderline or dimorphous leprosy, and is has characteristics of both other forms. Lepromatous leprosy symptoms are a chronically stuffy nose and many skin lesions and nodules on the front and back of the body. Sensation loss starts at the fingers and toes and may only affect a small patch of skin to begin with. The loss of sensation can lead to unnoticed injuries which may in turn become infected. Sensation loss may only affect a small patch of skin. Again, the loss of sensation can lead to unnoticed injuries and infection. Dimorphous leprosy creates skin lesions characteristic of the lepromatous and tuberculoid forms.
Causes of Leprosy
Common causes of Leprosy
- Loss of sensation.
- Sensation loss.
Symptoms of Leprosy
Common Symptoms of Leprosy
- Skin lesions.
- Skin lesions that do not heal after several weeks to months
- Numbness or absent sensation in the hands and arms, or feet and legs
- Muscle weakness .
Treatment of Leprosy
Common Treatment of Leprosy
- PB patients treated with MDT are cured within six months.
- MB patients treated with MDT are cured within 12 months.
- Patients are no longer infectious to others after the first dose of MDT. In other words, transmission of leprosy is interrupted.
- There are virtually no relapses, i.e. recurrences of the disease after treatment is completed.
- No resistance of the bacillus to MDT has been detected.
- MDT has prevented about four million people from being disabled.